B. G. Nordestgaard, M. J. Chapman, and S. E. Humphries, Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society, Eur Heart J, vol.34, pp.3478-3490, 2013.

M. Cuchel, E. Bruckert, and H. N. Ginsberg, Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society, Eur Heart J, vol.35, pp.2146-2157, 2014.

M. Benn, G. F. Watts, A. Tybjaerg-hansen, and B. G. Nordestgaard, Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication, J Clin Endocrinol Metab, vol.97, pp.3956-3964, 2012.

R. Do, N. O. Stitziel, and H. H. Won, Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction, Nature, vol.518, pp.102-106, 2015.

B. Sjouke, D. M. Kusters, and I. Kindt, Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome, Eur Heart J, vol.36, pp.560-565, 2015.

Z. Reiner, A. L. Catapano, D. Backer, and G. , EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur Heart J, vol.32, pp.1769-1818, 2011.

A. L. Catapano, G. I. , D. Backer, and G. , ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR), Atherosclerosis, vol.253, pp.281-344, 2016.

, Association/American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Circulation, vol.107, pp.1681-1691, 2003.

T. Jernberg, P. Hasvold, M. Henriksson, H. Hjelm, M. Thuresson et al., Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective, Eur Heart J, vol.36, pp.1163-1170, 2015.

K. A. Fox, K. F. Carruthers, and D. R. Dunbar, Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study), Eur Heart J, vol.31, pp.2755-2764, 2010.

E. Rapsomaniki, A. Shah, and P. Perel, Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients, Eur Heart J, vol.35, pp.844-852, 2014.

D. Nanchen, B. Gencer, and O. Muller, Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes, Circulation, vol.134, pp.698-709, 2016.

S. A. Rerup, L. E. Bang, and U. M. Mogensen, The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction, Am Heart J, vol.181, pp.35-42, 2016.

A. M. Galema-boers, M. J. Lenzen, S. R. Engelkes, E. J. Sijbrands, R. Van-lennep et al.,

, Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy, J Clin Lipidol, vol.12, pp.409-416, 2018.

N. Mata, R. Alonso, and L. Badimon, Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART), Lipids Health Dis, vol.10, p.94, 2011.

S. A. Murphy, C. P. Cannon, and M. A. Blazing, Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial, J Am Coll Cardiol, vol.67, pp.353-361, 2016.

S. Beliard, A. Millier, and V. Carreau, The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients, J Clin Lipidol, vol.10, pp.1129-1136, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01479071

S. Beliard, V. Carreau, and A. Carrie, Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects, Atherosclerosis, vol.234, pp.136-141, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01859380

, We could eventually also include another Kaplan-Meier curve, showing the freedom from recurrent cardiovascular events regarding the type of recurrent event (coronary revascularization, stroke, PAD, unstable angina and myocardial infarction)